Results 51 to 60 of about 2,292,383 (315)

Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation

Open Medicine, 2017
Liver injury is one of the most common complications in patients after kidney transplantation. Bicyclol tablets possess obvious anti-inflammatory and liver-protective functions. This study aimed to explore the clinical effect of preventive application of
Shang Wenjun, Feng Yonghua, Li Jinfeng, Wang Xinzhou, Xie Hongchang, Feng Guiwen   +5 more
doaj   +1 more source

Assessment of hypertension-mediated organ damage in children and adolescents with hypertension

Blood Pressure, 2023
Purpose: Arterial hypertension (HT) is a main, potentially reversible cardiovascular risk factor. Long lasting HT leads to hypertension mediated organ damage (HMOD) of heart, vascular bed, and kidneys.
Michał Pac, Łukasz Obrycki, Jan Koziej, Krzysztof Skoczyński, Anna Starnawska-Bojsza, Mieczysław Litwin   +5 more
doaj   +1 more source

Mortality after kidney transplantation: 10-year outcomes

Cirugía y Cirujanos, 2022
Objectives: In the past decade, advances in immunological therapy have increased the survival of kidney recipients and their grafts. However, it has not achieved the desired level of improvement.
Turgut Piskin, Arife Simsek, Sait Murat-Dogan, Baha T. Demirbas, Bulent Unal, Ismail O. Yildirim, Sibel A. Toplu, Haci B. Berktas, Hatice Can, Ebru I. Coskun, Mukadder Sanli, Huseyin Gurbuz, Mehmet S. Arslan, Zeynep Piskin, Julide Yagmur, Fatih Oguz, Yasar Bayindir, Ozkan Ulutas, Hulya Taskapan, Idris Sahin   +19 more
doaj   +1 more source

Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

American Journal of Kidney Diseases, 2019
RATIONALE & OBJECTIVE Hepatitis C virus (HCV) infection is common among maintenance dialysis patients. Few studies have examined both dialysis survival and transplantation outcomes for HCV-seropositive patients because registry data sets lack information
D. Sawinski, K. Forde, V. Lo Re, D. Goldberg, Jordana B. Cohen, J. Locke, R. Bloom, C. Brensinger, J. Weldon, J. Shults, P. Reese   +10 more
semanticscholar   +1 more source

Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. [PDF]

, 2011
Technological advances in molecular and in silico research have enabled significant progress towards personalized transplantation medicine. It is now possible to conduct comprehensive biomarker development studies of transplant organ pathologies ...
Khatri, Purvesh, Roedder, Silke, Sarwal, Minnie M, Vitalone, Matthew   +3 more
core   +3 more sources

Clinical outcomes of simultaneous pancreas-kidney transplantation in elderly type II diabetic recipients

Diabetology & Metabolic Syndrome
The effect of age on outcomes after simultaneous pancreas-kidney transplantation (SPK) among type II diabetes (T2DM) recipients remains inconclusive. This study aimed to analyze the relationship between the age at time of transplantation and mortality ...
Yu Cao, Jie Zhao, Gang Feng, Zhen Wang, Jianghao Wei, Yang Xu, Chunbai Mo, Wenli Song   +7 more
doaj   +1 more source

Kidney transplantation. Modern trends in kidney transplantation. [PDF]

, 1977
Trends in renal transplantation stem from recognition of the virtues and drawbacks of this kind of treatment and from a better appreciation of the interrelationship between transplantation and ...
Putnam, CW, Starzl, TE, Weil, R
core  

Experimental rat models of chronic allograft nephropathy: a review [PDF]

, 2014
Chronic allograft nephropathy (CAN) is the leading cause of late allograft loss after renal transplantation (RT), which continues to remain an unresolved problem. A rat model of CAN was first described in 1969 by White et al. Although the rat model of RT
Haylor, John, Shrestha, Badri
core   +2 more sources

Bortezomib in Kidney Transplantation [PDF]

Journal of Transplantation, 2010
Although current therapies for pretransplant desensitization and treatment of antibody-mediated rejection (AMR) have had some success, they do not specifically deplete plasma cells that produce antihuman leukocyte antigen (HLA) antibodies. Bortezomib, a proteasome inhibitor approved for the treatment of multiple myeloma (a plasma cell neoplasm ...
Rajeev Raghavan, Abdallah Jeroudi, Katafan Achkar, A. Osama Gaber, Samir J. Patel, Abdul Abdellatif   +5 more
openaire   +3 more sources

Racial disparities in preemptive referral for kidney transplantation in Georgia

Clinical Transplantation, 2018
Racial disparities persist in access to kidney transplantation. Racial differences in preemptive referral, or referral prior to dialysis start, may explain this discrepancy.
J. Gander, Xingyu Zhang, L. Plantinga, S. Paul, M. Basu, S. Pastan, E. Gibney, E. Hartmann, L. Mulloy, C. Zayas, R. Patzer   +10 more
semanticscholar   +1 more source